Clinical Trial: Stem Cell Therapy in Duchenne Muscular Dystrophy

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: The Role of Autologous Bone Marrow Mononuclear Cell Therapy in Duchenne Muscular Dystrophy

Brief Summary: The purpose of this study was to study the effect of stem cell therapy in patients with Duchenne Muscular Dystrophy.

Detailed Summary:
Sponsor: Neurogen Brain and Spine Institute

Current Primary Outcome: Manual Muscle Testing [ Time Frame: 1 year ]

Original Primary Outcome: Same as current

Current Secondary Outcome: Brooke and Vignos Scale [ Time Frame: 1 year ]

Original Secondary Outcome: Same as current

Information By: Neurogen Brain and Spine Institute

Dates:
Date Received: September 12, 2014
Date Started: January 2009
Date Completion:
Last Updated: September 23, 2016
Last Verified: September 2016